Anavex Life Sciences Corp (AVXL)

[falconer66a]

No Cherries Today. Big Fat Data Apples.

cherry pick data and cherry pick release of that data..

.
Better learn to read graphs of outcome data. Nothing whatsoever "cherry picked" in today's outcomes data. Thoroughly positive for each datum.

But, some will have to wait for the same data from the subsequent Phase 3 clinical trial. They, also, will be entirely positive. Approval by the FDA will follow. Only difference will be even better therapeutic scores. This Phase 2 trial ran for only 11 weeks at the target dosage levels. During that short period major score improvements for every tested outcome. When the next trial runs far longer, scores will continue to improve beyond the first 11 weeks. FDA will be compelled to approve.

Now, but a matter of time.